Success Metrics

Completion Rate
0%(0/4)
Active Trials
0(0%)
Terminated
4(100%)

Phase Distribution

Ph phase_4
3
75%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 4 finished

Non-Completion Rate

100.0%

4 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Terminated(4)

Detailed Status

Terminated4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (25.0%)
Phase 43 (75.0%)

Trials by Status

terminated4100%

Recent Activity

0 active trials
Showing 4 of 4
terminatedphase_4

Dronedarone Pattern of Use in Patients Scheduled for Elective Cardioversion (ELECTRA)

NCT01026090
terminatedphase_4

Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers

NCT01135017
terminatedphase_4

Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial Enlargement

NCT01198873
terminatedphase_3

Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy

NCT01151137

Clinical Trials (4)

Showing 4 of 4 trials
NCT01026090Phase 4

Dronedarone Pattern of Use in Patients Scheduled for Elective Cardioversion (ELECTRA)

Terminated
NCT01135017Phase 4

Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers

Terminated
NCT01198873Phase 4

Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial Enlargement

Terminated
NCT01151137Phase 3

Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4